SCHEMBL7856282

SCHEMBL7856282

CC(C)c1cc([N+](=O)[O-])ccc1C(N)=O

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.59
ALDH1A1 P00352 7/20 0.49
CYP3A4 P08684 4/20 0.49
TDP1 Q9NUW8 2/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 2/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
POLB P06746 2/20 0.47
MEN1 O00255 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
RAB9A P51151 1/20 0.46
LMNA P02545 2/20 0.44
MITF O75030 1/20 0.44
GAA P10253 1/20 0.44
CASP1 P29466 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28192073 0.87 KMT2A (0.55) KMT2AALDH1A1CYP3A4TSHRSMN1; SMN2
SCHEMBL1644599 0.85 ALDH1A1 (0.58) KMT2AALDH1A1CYP3A4TDP1ALOX15
SCHEMBL7341366 0.85 KMT2A (0.54) KMT2AALDH1A1CYP3A4TDP1ALOX15
SCHEMBL10786974 0.82 MAPT (0.43) KMT2AALDH1A1CYP3A4TDP1ALOX15
SCHEMBL2354936 0.79 ALDH1A1 (0.62) KMT2AALDH1A1CYP3A4TDP1ALOX15
SCHEMBL6398309 0.79 KMT2A (0.71) KMT2AALDH1A1CYP3A4TDP1ALOX15
SCHEMBL11107197 0.79 CES2 (0.52) ALDH1A1TDP1SMN1; SMN2POLBRAB9A
SCHEMBL28203029 0.79 KMT2A (0.47) KMT2AALDH1A1CYP3A4TSHRSMN1; SMN2
SCHEMBL8683857 0.79 KMT2A (0.47) KMT2AALDH1A1CYP3A4TDP1ALOX15
SCHEMBL1094136 0.78 KMT2A (0.65) KMT2AALDH1A1CYP3A4TDP1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104003939-B Diaryl substitution thiohydantoin class compound and preparation method and application 山东大学 2017-07-07 CN disclosed
EP-0819113-B1 BENZAMIDES FOR NEURODEGENERATIVE DISORDER TREATMENT CENTAUR PHARMACEUTICALS INC (US) 2001-06-27 EP disclosed